Secondary Prevention of coRonary Events After Discharge From Hospital (SPREAD)

NCT ID: NCT01207700

Last Updated: 2014-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

806 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized, open trial comparing post discharge interventions by community health workers (CHW) to standard care in acute coronary syndrome (ACS) patients.

This trial will be conducted in 10 hospitals in India/different parts(both secondary and tertiary care). A total of 800 patients will be recruited, with equal allocation to SPREAD interventions and control groups (usual care)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inclusion criteria:

Consenting patients being discharged after an acute coronary event such as unstable angina, acute myocardial infarction, or after coronary intervention (CABG surgery or PCI).

Exclusion criteria:

Patients with other terminal/ debilitating illness, (e.g., advanced cancer, disabling stroke) those not expected to survive for the study duration, those with dementia and psychiatric illness or patients unlikely to comply with study requirements, including regular follow up.

OUTCOME MEASURES:

1. Feasibility
2. Difference in adherence to specific medications for secondary prevention of CAD (Coronary Artery Diseases) compared to the control group, at one year.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CHW based intervention post ACS

CHW trained and supervised for intervening upon post ACS patients to improve adherence to evidence based care

Group Type EXPERIMENTAL

CHW based intervention post ACS

Intervention Type BEHAVIORAL

CHW is trained and supervised to provide interventions that could improved adherence to post ACS care

Standard Care

Patients will be followed upto 12 months without a community health worker intervention as per standard practices of the hospital

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CHW based intervention post ACS

CHW is trained and supervised to provide interventions that could improved adherence to post ACS care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Consenting patients being discharged after an acute coronary event such as unstable angina, acute myocardial infarction, or after coronary intervention (CABG surgery or PCI).

Exclusion Criteria

* Patients with other terminal/ debilitating illness, (e.g., advanced cancer, disabling stroke) those not expected to survive for the study duration, those with dementia and psychiatric illness or patients unlikely to comply with study requirements, including regular follow up
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart and Lung Institute

OTHER

Sponsor Role collaborator

St. John's Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Alben Sigamani

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. Rajeev Gupta, MD, PHD

Role: PRINCIPAL_INVESTIGATOR

Fortis Escorts Hospital, Jaipur

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Krishna Institute of Medical Science Ltd

Secunderabad, Aandhra Pradesh, India

Site Status

Mahavir Hospital & Research Centre

Hyderabad, Andhra Pradesh, India

Site Status

Nanjappa Hospital

Shimoga, Karnataka, India

Site Status

Caritas Hospital

Kottayam, Kerala, India

Site Status

Bhopal Memorial Hospital

Bhopal, Madhya Pradesh, India

Site Status

Avanti Institute of Cardiology

Nagpur, Maharashtra, India

Site Status

Poona Hospital

Pune, Maharashtra, India

Site Status

Mahatma Gandhi Institute of Medical Science Sevagram

Wardha, Maharashtra, India

Site Status

Sir Ganga Ram Hospital

New Delhi, New Delhi, India

Site Status

Fortis Escorts Hospital

Jaipur, Rajasthan, India

Site Status

Rajamuthiah Medical College & Hospital

Annāmalainagar, Tamil Nadu, India

Site Status

PSG Hospital

Coimbatore, Tamil Nadu, India

Site Status

Sahara Hospital

Lucknow, Uttar Pradesh, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

References

Explore related publications, articles, or registry entries linked to this study.

Xavier D, Gupta R, Kamath D, Sigamani A, Devereaux PJ, George N, Joshi R, Pogue J, Pais P, Yusuf S. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial. Lancet Diabetes Endocrinol. 2016 Mar;4(3):244-253. doi: 10.1016/S2213-8587(15)00480-5. Epub 2016 Feb 6.

Reference Type DERIVED
PMID: 26857999 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NO1-HV-98215/SJRI - DCT/SPREAD

Identifier Type: -

Identifier Source: org_study_id